AC8
Click for more information
0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Neuvis Capsule Successfully Completes Phase I Study, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. bigdaddymoney
    521 Posts.
    lightbulb Created with Sketch. 42
    clock Created with Sketch.
    14/09/20
    10:32
    Post #: 47314800
    Just a bit of caution here. Although this is great news we are a long way from successful phase III trials. A lot could happen between now and then.
    AC8 Price at posting: 17.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Exciting new copper-gold discoveries at Tarraji-Yampi: Dive into the strong drilling results now
right-arrow Created with Sketch.
NEWS Second consecutive quarter of record revenue driven by strong sales growth in market-leading medical products!
right-arrow Created with Sketch.
NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
right-arrow Created with Sketch.
NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
NEWS FDA clearance secured for AI-enabled EchoSolv AS – ready for rapid U.S. market launch
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.